Regenerative healing restores the body to the same level of function as it had prior to injury or disease.
Historically, regenerative healing that brings the body back to the same level of function as it had before injury or disease has been pursued as far back as the early 20th century.1 By the 1970’s, science was beginning to document observations that fetuses in early gestation experienced a healing process vastly different from what is experienced outside of the womb.2,3
With the advent of in utero surgery in the 1980’s, direct observation of clinical outcomes of fetal healing demonstrated that it was regenerative in nature. Research has shown that this occurs because the placental tissues, particularly the umbilical cord and amniotic membrane, have innate healing properties. More importantly, these properties can be preserved and transplanted to other environments to promote healing.
When processed appropriately, allograft birth tissue retains these properties and effectively applies them to unrelated hosts.4-6 The transplantation of this biology into mature tissue provides a means of disrupting the inflammatory cycle of repair inherent to adult tissue and drives a process of restorative and regenerative repair.
With more than 36 years of National Institute of Health funded research efforts, BioTissue has developed and commercialized proprietary technology that preserves the innate properties of the umbilical cord and amniotic membrane. The preservation of these key components provides allografts that promote the modulation of inflammation to support healing without the formation of scar tissue or adhesions and to minimize the pain that is customarily associated with such inflammation.